Kindly Md, Inc. KDLY
We take great care to ensure that the data presented and summarized in this overview for Kindly MD, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in KDLY
Top Purchases
Top Sells
About KDLY
Insider Transactions at KDLY
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2025
|
Jared Barrera Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,400
+22.34%
|
-
|
|
Sep 22
2025
|
Timothy Pickett Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
92,246
+12.43%
|
-
|
|
Sep 22
2025
|
Eric Stanton Weiss Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,781
+50.0%
|
-
|
|
Sep 22
2025
|
Andrew John Creighton Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
601,503
+13.9%
|
-
|
|
Sep 22
2025
|
David F Bailey Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
751,879
+5.94%
|
-
|
|
Sep 22
2025
|
Amanda Fabiano Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,135,337
+47.5%
|
-
|
|
Sep 22
2025
|
Gregory Elias Xethalis Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,781
+50.0%
|
-
|
|
Sep 22
2025
|
Perianne Boring Mc Nulty Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,781
+50.0%
|
-
|
|
Sep 22
2025
|
Mark W Yusko Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,781
+4.85%
|
-
|
|
Sep 22
2025
|
Tyler Matthew Evans Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
601,503
+16.65%
|
-
|
|
Sep 22
2025
|
Charles Phillip Blackburn Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,781
+50.0%
|
-
|
|
Aug 14
2025
|
Tyler Matthew Evans Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,232,114
+48.08%
|
-
|
|
Aug 14
2025
|
Andrew John Creighton Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,232,114
+41.67%
|
-
|
|
Aug 14
2025
|
David F Bailey Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,160,572
+50.0%
|
-
|
|
May 12
2025
|
Timothy Pickett Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,780
+22.52%
|
$28,780
$1.61 P/Share
|
|
May 12
2025
|
Amy Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,838
+26.44%
|
$1,838
$1.61 P/Share
|
|
May 12
2025
|
Gary Seelhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,838
+26.44%
|
$1,838
$1.61 P/Share
|
|
May 12
2025
|
Christian S. Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,838
+26.44%
|
$1,838
$1.61 P/Share
|
|
Oct 24
2024
|
Amy Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+50.0%
|
$837
$1.05 P/Share
|
|
Oct 24
2024
|
Adam Cox COO |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+11.0%
|
$9,000
$1.05 P/Share
|
Last 12 Months Summary
Buy / Acquisition
22.4M
Shares
From
14
Insiders
| Grant, award, or other acquisition | 22.4M shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders